Teresa Marie Volner alias The Glucose Genome Guru
Website · totalcarehealthsolutions.com
Practice location
6308 College Blvd
Overland Park, KS 66211
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 20 health claims, 14 run counter to or conflict with the published evidence, and 6 were not independently checked.
- Primary persuasion tactic: Diabetes doom framing.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend, with no clear disclosure.
- Gives advice beyond what their license covers.
Teresa Volner is serving up the full root-cause catechism: diabetes, DNA, oxidative stress, detox, supplements, coaching, and a free blueprint call to tie the whole bundle together. It’s the sort of polished metabolic mysticism that makes blood sugar sound like a personality test with a checkout page.
High grift signals
Score breakdown
Direct answer
Teresa Marie Volner is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. 65-2871) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Genetic testing can predict diabetes, Winners in Diabetes Program, The WINNERS in Diabetes Full Program, to struggle alone with diabetes, and Q: Can genetic testing predict diabetes?, conditions that belong with appropriately board-certified physicians. Those same pages route patients toward supplements, lab panels, and paid programs that Teresa Marie Volner profits from.
Key findings
- Fear Mongering: This uses diabetes complications to scare the viewer into buying the program, even though the page is pitching unproven genetic and detox add-ons rather than standard diabetes care.see section ↓
- Claim "The WINNERS in Diabetes Program can restore balance and help with blood sugar stability,…": not supported by peer-reviewed evidence.see section ↓
- Claim "Detox programs can reset the body and restore natural balance for metabolic problems": mixed in the medical literature.see section ↓
- NPI registry confirms Teresa Volner as Chiropractor (DC) in Kansas (NPI 1871717009).see section ↓
- Teresa Marie Volner shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Teresa Marie Volner is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. 65-2871), these advertised activities appear outside Teresa Marie Volner's license (including conditions they merely list as ones they treat): Manage Type 2 Diabetes with Genetic Testing, Type 2 diabetes can be traced to…see section ↓
- 24 of 24 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
In their own published words, they present themselves as qualified to treat, or give advice on, 14 conditions or treatments. A chiropractic license covers the spine, joints and muscles, and the scope review placed each one outside it. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Manage Type 2 Diabetes with Genetic Testing.
Manage Type 2 Diabetes with Genetic Testing
No specific health claims of theirs were cross-checked against the literature.
“Manage Diabetes With Genetic Testing & Transform With Certainty.”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Type 2 diabetes can be traced to DNA / genetics as the hidden root cause.
Type 2 diabetes can be traced to DNA / genetics as the hidden root cause
- Supports
- The claim has limited support only in the narrow sense that genetics contributes to susceptibility to type 2 diabetes, and risk can run in families, but no listed paper here directly addresses diabetes genetics . In mainstream diabetes research, many common genetic variants have been associated with type 2 diabetes, and family aggregation is well established, but this does not mean DNA is the single hidden root cause.
- Contradicts
- The claim is too strong because type 2 diabetes is not explained by DNA alone; it is a multifactorial disease driven by the interaction of inherited susceptibility with body weight, diet, physical inactivity, aging, visceral adiposity, sleep, medications, and other environmental and metabolic factors. The listed papers are unrelated to diabetes genetics and therefore do not supply direct support for the claim . Evidence from major diabetes guidelines and reviews generally treats genetics as one risk factor among many, not as a hidden sole root cause.
- Mainstream view
- The mainstream medical view is that type 2 diabetes is a complex multifactorial disease with substantial genetic heritability but no single genetic root cause. Genetics influences susceptibility, yet disease onset and progression depend heavily on environmental and lifestyle factors, insulin resistance, beta-cell dysfunction, and other non-genetic contributors.
Papers listed for this claim:[1][2][3][4][5][6][7][8]
“What If the Secret to Reversing Type 2 Diabetes Has Been in Your DNA All Along?”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism.
The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism
- Supports
- No high-quality evidence from the listed papers supports the claim that the WINNERS in Diabetes Program can restore balance, improve blood sugar stability, energy, digestion, or metabolism. The listed papers are unrelated clinical guidelines and methodological articles, not studies of this program or its outcomes.
- Contradicts
- The claim is not supported by the listed evidence base, because none of the listed papers evaluate the WINNERS in Diabetes Program or show that such a program restores physiologic “balance” or improves glycemic control, energy, digestion, or metabolism. The strongest available evidence in the list is about other conditions and about evidence-quality methods, so it cannot be used as direct support for this claim. The claim also uses broad wellness language that is not a standard clinical endpoint and is not established by the cited literature.
- Mainstream view
- Mainstream medical and scientific practice would require direct evidence from randomized trials or systematic reviews showing improved diabetes outcomes before accepting claims about a program restoring balance or improving blood sugar stability, energy, digestion, or metabolism. Based on the listed papers and the absence of direct program-specific evidence, the claim should be considered unproven and not established.
Papers listed for this claim:[1][3][2][4][6][5][7][9]
“The WINNERS in Diabetes Program is a personalized system designed to restore balance to your body from blood sugar stability to energy, digestion, and metabolism.”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure DNA and oxidative stress testing can guide personalized diabetes management.
DNA and oxidative stress testing can guide personalized diabetes management
- Supports
- There is moderate supporting evidence that genetic information (pharmacogenomics/pharmacogenetics) is relevant to diabetes management, particularly in understanding variability in response to oral antidiabetic drugs and in conceptual precision medicine frameworks. Multiple reviews describe how variants in genes affecting drug pharmacokinetics and pharmacodynamics can influence glycemic response, hypoglycemia risk, and other treatment outcomes, and propose that pharmacogenomics could enable genetically tailored therapeutic plans in type 2 diabetes. These reviews emphasize that integrating genetic profiling into treatment decisions has theoretical potential to improve efficacy and safety, and they outline mechanisms and candidate variants that might be used in future personalized care. Similarly, oxidative stress is strongly implicated in the pathophysiology and complications of diabetes, and systematic and narrative reviews show that biomarkers such as malondialdehyde, F2-isoprostanes, 8‑hydroxydeoxyguanosine, glutathione, superoxide dismutase, and related measures are consistently elevated in type 2 diabetes and correlate with disease progression and complications. Some authors explicitly suggest that measuring oxidative stress biomarkers in clinical trials could help individualize treatment in terms of drug choice and patient selection, and more recent work highlights oxidative stress and related biomarkers as part of emerging multimarker panels for precision diabetes care, with potential roles in risk stratification and monitoring of complications. A systematic review of genetic and transcriptomic factors linked to oxidative stress in late diabetic complications reports that antioxidants in dietary and supplement form can improve some metabolic and biochemical parameters in patients with complications, and it identifies oxidative stress pathways as plausible targets for future personalized approaches. Together, this body of evidence supports the general concept that DNA-related factors and oxidative stress biology are mechanistically and prognostically important in diabetes, and that in principle they could contribute to personalized management, especially in research settings.
- Contradicts
- Despite these conceptual and mechanistic links, high‑quality clinical evidence that routine DNA testing or oxidative stress biomarker testing currently guides and improves day‑to‑day diabetes management is weak or absent. Pharmacogenetic and pharmacogenomic reviews repeatedly emphasize that, although many associations between genetic variants and drug response have been described, most studies are small, heterogeneous, observational, and underpowered, and they often lack replication, standardized outcomes, and robust experimental designs. A key pharmacogenetics review notes that positive predictive value and penetrance data for tested variants are still lacking and explicitly states that genetic testing has not yet been incorporated into national guidelines for type 2 diabetes treatment, indicating that clinical utility has not been established. Systematic reviews of diabetes pharmacogenetics call for better designed randomized trials and standardized reporting before genotype‑guided therapy can be recommended, underscoring that current evidence is largely exploratory rather than practice‑changing. On the oxidative stress side, recent high‑quality assessments of oxidative stress biomarkers in type 2 diabetes conclude that, despite extensive associative evidence, no oxidative stress biomarker has consistently demonstrated incremental prognostic value beyond standard cardiometabolic risk models sufficient to justify routine clinical implementation. Other systematic reviews examining genetic and transcriptomic factors related to oxidative stress in late complications of type 2 diabetes explicitly report that current evidence does not support using these genetic or transcriptomic markers as predictive or prognostic tools in clinical practice, and that antioxidant‑targeted strategies remain experimental, with heterogeneous and often short‑term interventions that do not establish long‑term clinical benefit. Lifestyle‑based RCTs that measure oxidative stress markers show that interventions such as intensive exercise programs can change specific oxidative biomarkers (for example, decreasing RNA oxidation) but they do not demonstrate that these biomarkers are used to tailor therapy or that biomarker‑guided decisions improve hard clinical outcomes compared with standard guideline‑based care. Overall, there is a clear gap between mechanistic/prognostic research and clinical decision‑making: neither major diabetes guidelines nor evidence‑based hypertension or nutrition guidelines incorporate routine DNA or oxidative stress testing as a recommended tool for personalizing diabetes therapy. Instead, they rely on traditional clinical factors (glycemic control, comorbidities, cardiovascular and kidney status, weight, hypoglycemia risk) to guide treatment choices, which contradicts the influencer’s implication that DNA and oxidative stress tests are currently established tools for personalized diabetes management.
- Mainstream view
- The mainstream medical and scientific position is that while pharmacogenomics and oxidative stress biology are promising research areas for future precision diabetes care, routine DNA testing and oxidative stress biomarker testing are not currently recommended or widely used to guide individualized diabetes management in clinical practice. Major diabetes care frameworks and national guidelines base treatment choices on clinical parameters such as HbA1c, body weight, comorbid cardiovascular or kidney disease, risk of hyp
Papers listed for this claim:[1][2][3][4][6][5][7][8][10][11][12][13]
“Manage Type 2 Diabetes with DNA and Oxidative Stress Testing”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The program helps prevent kidney issues, nerve damage, and vision loss in diabetes.
The program helps prevent kidney issues, nerve damage, and vision loss in diabetes
- Supports
- The listed papers do not directly evaluate a diabetes program for preventing kidney disease, neuropathy, or vision loss, so they do not supply direct support for the claim. The closest relevant paper is a guideline on hypertension management, and blood pressure control is a recognized component of reducing diabetic kidney and eye complications in appropriate patients, but that inference is indirect rather than a direct test of the influencer’s program . Major nutrition and clinical guideline papers in the list are about other conditions and do not support this diabetes-specific prevention claim .
- Contradicts
- There is no direct peer-reviewed evidence in the listed papers that the program itself prevents diabetic kidney issues, nerve damage, or vision loss. The claim is too broad unless the program has been shown in randomized trials or guidelines to improve glycemic control, blood pressure, and other risk factors linked to microvascular complications; those data are not present in the list . Evidence from diabetes care more broadly shows that complication prevention depends on sustained control of glucose, blood pressure, and other risk factors, not on an unspecified program as a standalone intervention, so the claim is unsupported as stated. The listed guideline and evidence-methodology papers are not disease-specific efficacy evidence for diabetes complications .
- Mainstream view
- Mainstream medical view is that diabetic kidney disease, neuropathy, and retinopathy are prevented or delayed by evidence-based diabetes management, especially tight but safe glycemic control, blood pressure control, lipid management, smoking cessation, regular screening, and use of indicated medications such as ACE inhibitors/ARBs or SGLT2 inhibitors when appropriate. An unspecified influencer program is not considered an evidence-based preventive treatment unless it has direct clinical trial evidence and guideline endorsement, which is not shown in the listed papers.
Papers listed for this claim:[1][3][2][4][6][5][7][18]
“Assess your genetic odds to help prevent kidney issues, nerve damage and vision loss.”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Winners in Diabetes Program.
Winners in Diabetes Program
- Supports
- No high-quality evidence from the listed papers supports the claim that the WINNERS in Diabetes Program can restore balance, improve blood sugar stability, energy, digestion, or metabolism. The listed papers are unrelated clinical guidelines and methodological articles, not studies of this program or its outcomes.
- Contradicts
- The claim is not supported by the listed evidence base, because none of the listed papers evaluate the WINNERS in Diabetes Program or show that such a program restores physiologic “balance” or improves glycemic control, energy, digestion, or metabolism. The strongest available evidence in the list is about other conditions and about evidence-quality methods, so it cannot be used as direct support for this claim. The claim also uses broad wellness language that is not a standard clinical endpoint and is not established by the cited literature.
- Mainstream view
- Mainstream medical and scientific practice would require direct evidence from randomized trials or systematic reviews showing improved diabetes outcomes before accepting claims about a program restoring balance or improving blood sugar stability, energy, digestion, or metabolism. Based on the listed papers and the absence of direct program-specific evidence, the claim should be considered unproven and not established.
Papers listed for this claim:[1][3][2][4][6][5][7][9]
“Winners in Diabetes Program”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The WINNERS in Diabetes Full Program.
The WINNERS in Diabetes Full Program
No specific health claims of theirs were cross-checked against the literature.
“The WINNERS in Diabetes Full Program”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure to struggle alone with diabetes.
to struggle alone with diabetes
PubMed indexes 5 randomized human trials on this intervention and outcome. Our literature check did not establish which way they point. No randomized trials in people are reported to test whether chiropractic treatment improves diabetes; the limited reports are uncontrolled or involve healthy subjects.
- Randomized human trials
- 5
- Animal or in-vitro only
- 6
Search: (spinal manipulation OR chiropractic) AND (diabetes)
- Supports
- There is no high-quality evidence such as randomized controlled trials, systematic reviews, or major guidelines showing that chiropractic treatment can meaningfully improve glycemic control or serve as an effective treatment for diabetes itself. Existing publications are limited to case reports and very small, uncontrolled series suggesting transient blood glucose changes after spinal manipulation or posture correction in individual patients with diabetes, which are hypothesis-generating at best and not definitive therapy evidence. The listed guideline and methods papers (on hypertension, nutrition, headache, transfusion, colchicine, and GRADE methodology) do not address chiropractic treatment for diabetes and therefore do not support the influencer’s claim.
- Contradicts
- Major diabetes guidelines emphasize evidence-based management with lifestyle modification, structured diabetes education, pharmacologic therapy (such as insulin, oral glucose-lowering agents), and multidisciplinary medical care; they state that manual therapies including chiropractic manipulation lack randomized controlled trial data specific to diabetes and should not replace standard medical treatment. High-quality randomized trials and guideline-driven models show that improved diabetes outcomes come from specialist-led medical care, continuous glucose monitoring–guided insulin titration, patient-centered self-management programs, and integrated digital health platforms, not from chiropractic adjustments. The very limited experimental work on spinal manipulation and glycemia in healthy subjects has found no significant changes in blood glucose, arguing against a strong direct effect of manipulation on glycemic control. Overall, the existing evidence base is weak, heavily reliant on anecdotal case reports, and contradicted by guideline statements that manual therapies have no proven role in treating diabetes itself.
- Mainstream view
- The mainstream medical and scientific position is that diabetes is a chronic metabolic disease that should be managed with established interventions: diet and physical activity, structured self‑management education, pharmacologic therapy (including insulin and modern glucose‑lowering drugs), and coordinated care by diabetes specialists and primary care teams. Chiropractic care is not recognized as a treatment for diabetes; at most it may be used as an adjunctive modality for musculoskeletal complaints (such as low back pain) in people who happen to have diabetes, with no expectation that it will control blood sugar or replace standard diabetes care. Major guidelines explicitly note the absence of randomized controlled trial data for chiropractic in diabetes and do not recommend it for glycemic management.
Papers listed for this claim:[1][2][3][5][4][6][7][8][19][20][21][22]
“to struggle alone with diabetes”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Why the WINNERS in Diabetes Program Changes Everything.
Why the WINNERS in Diabetes Program Changes Everything
No specific health claims of theirs were cross-checked against the literature.
“Why the WINNERS in Diabetes Program Changes Everything”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Q: Can genetic testing predict diabetes?.
Q: Can genetic testing predict diabetes?
No specific health claims of theirs were cross-checked against the literature.
“Q: Can genetic testing predict diabetes?”
Rule: K.S.A. 65-2871
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Do you have genetic tendencies toward insulin resistance?.
Do you have genetic tendencies toward insulin resistance?
No specific health claims of theirs were cross-checked against the literature.
“Do you have genetic tendencies toward insulin resistance?”
Rule: K.S.A. 65-2871
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Put Diabetes In Remission Forever!.
Put Diabetes In Remission Forever!
No specific health claims of theirs were cross-checked against the literature.
“Put Diabetes In Remission Forever!”
Rule: K.S.A. 65-2871
See every doc bro who says they can treat or advise on Diabetes and blood sugar
Teresa Marie Volner is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise DNA testing plus lifestyle and supplement recommendations will work for you as within their scope of practice.
DNA testing plus lifestyle and supplement recommendations will work for you
- Supports
- There is some randomized trial evidence that providing personalized, genotype‑based lifestyle or nutrition advice can modestly improve certain behaviors or intermediate outcomes compared with standard, population‑based advice. For example, the NOW trial found that adding nutrigenomics-guided advice to a standard weight-management program improved long‑term adherence to dietary fat and saturated fat guidelines and led to short‑ and medium-term improvements in body composition, although 12‑month body fat differences were not sustained. Lifestyle interventions in general (without DNA testing) have strong evidence for improving cardiometabolic risk factors, frailty, and cognition in specific at‑risk populations, as shown by large randomized trials and guideline‑driven programs for hypertension, nutrition, and chronic disease management. Major clinical guidelines for conditions like hypertension and inflammatory bowel disease consistently recommend individualized lifestyle measures (diet, physical activity, risk-factor control), and may include supplements such as specific vitamins or omega‑3 fatty acids in defined situations, but these recommendations are based on clinical factors rather than DNA testing.
- Contradicts
- High-quality evidence does not support a broad claim that DNA testing plus lifestyle and supplement recommendations will reliably “work” for most people or produce clinically meaningful advantages over standard, phenotype‑based lifestyle care. A recent meta‑analysis pooling randomized studies of genotype‑based dietary or physical activity advice found no significant benefit over general advice or advice based on lifestyle/phenotypic measures for changing behavior (standardized mean difference 0.00, 95% CI −0.11 to 0.11). This indicates that gene‑based advice does not improve diet or physical activity more than conventional counseling. Narrative and systematic reviews in personalized nutrition similarly conclude that despite nearly two decades of research and commercial direct‑to‑consumer testing, robust evidence that gene‑based dietary recommendations improve hard clinical outcomes (weight, diabetes incidence, cardiovascular events) is generally lacking. Some critical appraisals of nutrigenomics‑guided interventions emphasize that existing randomized trials are small, often show only modest or short‑term benefits, and are insufficient to determine effectiveness in routine clinical practice. An RCT of direct‑to‑consumer personal genetic testing providing cancer risk information found no significant effect on gynecologic cancer screening uptake, suggesting that receiving genetic risk results alone does not reliably change health behaviors. Major evidence‑based guidelines for hypertension, clinical nutrition (e.g., ASPEN‑FELANPE, ESPEN), headache, and transfusion therapy do not currently recommend routine DNA testing to guide lifestyle or supplement prescriptions for the general population.
- Mainstream view
- The mainstream medical and scientific position is that lifestyle interventions (dietary change, physical activity, risk-factor control, and sometimes selected supplements) are effective components of evidence‑based prevention and management for many chronic diseases, but these are typically guided by clinical assessment and established guidelines rather than by routine DNA testing. Precision nutrition and lifestyle genomics are viewed as promising research areas, with some early randomized trials showing small advantages in adherence or short‑term outcomes when genetic information is integrated into counseling, yet the overall evidence base is limited, heterogeneous, and does not demonstrate large, consistent, clinically meaningful benefits across populations. Current high‑quality evidence and major guidelines therefore consider consumer‑oriented DNA testing for general lifestyle and supplement recommendations as experimental or adjunct at best, not a validated standard of care for most people. DNA testing is clearly valuable for specific monogenic conditions and selected pharmacogenomic and cancer-risk contexts, but that is distinct from broad claims that such testing will make generic lifestyle and supplement plans “work” for everyone.
Papers listed for this claim:[1][2][3][4][5][6][7][8][35][36][37][38]
“It gives food, lifestyle, and supplement recommendations that will work for you.”
Rule: K.S.A. 65-2871
Teresa Marie Volner is not approved to offer Custom plans combine detox support, targeted nutrition, and clean supplements within a Chiropractor scope of practice under Kansas State Board of Healing Arts (Chiropractic).
Custom plans combine detox support, targeted nutrition, and clean supplements
- Supports
- There is substantial evidence that individualized or targeted nutrition plans can improve clinical outcomes in specific patient groups when designed according to established clinical nutrition principles and guidelines. Guidelines from ESPEN and ASPEN emphasize tailoring nutrition (macronutrients, micronutrients, route of administration) to the patient’s disease, nutritional status, and comorbidities, effectively endorsing “custom” nutrition plans but in a medical, guideline-driven framework rather than influencer-style programs. Randomized controlled trials of individualized or targeted nutritional interventions (for sarcopenia, pneumonia, COPD exacerbations, perioperative states, undernutrition, HIV) show benefits in muscle strength, physical function, nutritional status, readmission rates, some surgical outcomes, and quality of life, supporting the general concept that structured, tailored nutrition can be clinically useful. Some trials of nutritional “detoxification” or lifestyle programs report improvements in body composition, certain biomarkers of toxic metals or oxidative stress, and self-reported symptoms over short periods, suggesting that specific multi-component dietary interventions can influence selected laboratory and symptom measures.
- Contradicts
- Detox support as marketed in wellness and influencer programs is poorly supported by high-quality evidence; a critical review noted that commercial detox diets lack randomized controlled trial evidence for effectiveness in toxin elimination or weight management. Existing metabolic detoxification trials are short-term, often small, industry-associated, and focus on surrogate biomarkers rather than hard clinical outcomes; several report no significant changes in general physiological parameters (weight, blood pressure, standard metabolic panels) despite being well tolerated, indicating that benefits are modest, uncertain, and not clearly clinically meaningful. The concept of “clean supplements” (typically meaning free of certain additives or perceived toxins) is largely marketing language; major guidelines and trials in clinical nutrition and chronic disease management focus on evidence-based nutrient content, dosing, and safety, not on “clean” branding, and do not endorse generic supplement use for detox in otherwise healthy people. High-level guidelines for hypertension, inflammatory bowel disease, parenteral nutrition, and other conditions emphasize medical nutrition therapy and pharmacologic management rather than detox programs or broad supplement regimens for general health. Overall, the evidence base does not support broad claims that custom plans combining detox support, targeted nutrition, and clean supplements provide generalized, substantial health benefits for the average person beyond standard, guideline-based nutrition and medical care.
- Mainstream view
- Mainstream medical and scientific consensus supports individualized, evidence-based nutrition (medical nutrition therapy) tailored to specific diseases and nutritional states, implemented according to established guidelines such as ESPEN, ASPEN, and disease-specific nutrition recommendations. In contrast, the mainstream view is that commercial “detox” programs and generic supplement-based detox regimens lack robust evidence for clinically meaningful toxin removal or long-term health improvement, and should not replace standard care; detox claims are generally regarded as unproven or exaggerated. Supplements are used when there is a documented deficiency or specific indication, but routine “clean supplement” stacks for healthy individuals are not recommended in major guidelines. Custom nutrition plans are considered appropriate when they are medically indicated and guideline-driven; combining them with loosely defined detox support and marketing-driven clean supplements is not part of standard, evidence-based practice.
Papers listed for this claim:[1][3][2][4][6][5][7][8][39][24][40][41]
“Your custom plan combines detox support, targeted nutrition, and clean supplements chosen for your biology.”
Rule: K.S.A. 65-2871
Manipulation
transcript · cited
This uses diabetes complications to scare the viewer into buying the program, even though the page is pitching unproven genetic and detox add-ons rather than standard diabetes care. Likely motive: Push anxious readers into a paid consult and bundled program
“help prevent kidney issues, nerve damage and vision loss”
transcript · cited
The page wraps a diabetes coaching funnel in medical-sounding authority while presenting nonstandard DNA, oxidative stress, and detox services as if they were clinical necessities. Likely motive: Borrow clinical credibility to sell a premium program
“doctor-led transformation system”
transcript · cited
Client testimonials are used as proof of effectiveness instead of controlled evidence, and the page offers no serious data showing diabetes remission from these methods. Likely motive: Substitute testimonials for evidence
“What my clients say”
transcript · cited
The pitch centers on paid testing as the gateway to treatment, even though the page does not show that these tests are standard or necessary for diabetes management. Likely motive: Sell testing before selling the protocol
“DNA & Oxidative Stress Testing”
transcript · cited
The free consultation is a classic lead capture step that feeds into a higher-ticket diabetes program, tests, supplements, and coaching. Likely motive: Convert visitors into consult leads and paid buyers
“Book your FREE, no-commitment Blueprint Call.”
transcript · cited
A branded proprietary system packages consultations, testing, supplements, detox, and coaching into one monetized pathway. Likely motive: Sell a branded care pathway instead of evidence-based diabetes care
“The WINNERS in Diabetes Program”
source material
The page shows a Fullscript supplement storefront with no obvious FTC-style disclosure on the same surface explaining whether the clinician earns from dispensary sales or referrals. Likely motive: Normalize supplement shopping without telling viewers about the money flow
Commerce & grift map
The money flow looks like scare content about diabetes complications, then a paid consult, then DNA/oxidative stress testing, then a branded coaching program, with Fullscript supplements layered in as the ongoing monetization engine. It is the classic root-cause funnel: convince the viewer that standard diabetes care missed the hidden cause, then sell the proprietary test-stack-supplement pathway that allegedly found it.
Fullscript
Supplement / productPays providers to recommendLow confidence
- Affiliate commission
- Dispensing markup
- Wholesale-to-retail markup
Practitioner dispensary model: typical markup or commission on supplement sales routed through a branded storefront.
Supplements pitched
- Fullscript Supplements
“Fullscript Supplements Doctor-approved supplements that support healthy glucose regulation.”
Labs pitched
- DNA & Oxidative Stress Testing
“DNA & Oxidative Stress Testing Understand your genetic blueprint and cellular resilience.”
How the money flows
- Lab testing referralUndisclosed Paid DNA and oxidative stress testing is used as the gateway product in the diabetes funnel. “DNA & Oxidative Stress Testing”
“DNA & Oxidative Stress Testing”
- Supplement brand dealUndisclosed Fullscript dispensary supplements are embedded directly in the treatment pathway. “Fullscript Supplements Doctor-approved supplements that support healthy glucose regulation.”
“Fullscript Supplements Doctor-approved supplements that support healthy glucose regulation.”
- Paid wellness plan / membershipUndisclosed A branded diabetes program, coaching, and 1:1 sessions are sold as the main offer. “The WINNERS in Diabetes Program”
“The WINNERS in Diabetes Program”
- Affiliate / promo linkUndisclosed Outbound commerce store links with strong affiliate or practitioner-markup signals, but no clear FTC-style material-connection disclosure on the page.
Store links detected
- Browse SupplementsHigh likelihood
“Practitioner supplement dispensary”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- FullscriptBrand
Promoted commerce partner
- Fullscript SupplementsBrand
Named on a surface without a compensation disclosure
- DNA & Oxidative Stress TestingBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Learn: Is a chiropractor a medical doctor?
Stated: DR · Likely: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor, Internist · KS license T-01088.
Teresa Volner is presented as a doctor and diabetes authority, but the page does not clearly establish an MD or DO license. The bigger problem is credential inflation by implication: the site uses that title to market internal-medicine-style diabetes management, genetic interpretation, detox, and supplement selection as if broad medical competence were established.
- Chiropractor (DC), Doctor of Chiropractic
Kansas DCs are regulated by the Kansas State Board of Healing Arts. Scope is limited to chiropractic methods for musculoskeletal and nervous-system conditions, not general internal medicine, hormone replacement medicine, or primary disease management.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: high
Kansas chiropractors may examine, analyze, and diagnose the human body and its diseases using physical, thermal, manual, and X-ray methods; adjust misplaced tissue; manipulate or treat the body by manual, mechanical, electrical, or natural methods; use physiotherapy (light, heat, water, exercise); and use foods, food concentrates, or food extracts. Chiropractors are expressly prohibited from prescribing or administering medicine or drugs, performing surgery, or practicing obstetrics.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
24 of 24 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Manage Type 2 Diabetes with Genetic Testing Rule: K.S.A. 65-2871 Managing systemic disease (Type 2 Diabetes) is not affirmatively authorized in the chiropractic scope; the statute permits treatment by manual, mechanical, electrical, or natural methods and use of foods/food extracts, but does not authorize management of endocrine/metabolic disease. | Outside scope |
| Type 2 diabetes can be traced to DNA / genetics as the hidden root cause Rule: K.S.A. 65-2871 Diagnosing or attributing systemic disease etiology to genetic factors is not within the chiropractic scope; chiropractors may diagnose using physical, thermal, manual, and X-ray methods, but not genetic analysis or systemic disease causation. | Outside scope |
| The WINNERS in Diabetes Program can restore balance and help with blood sugar stability, energy, digestion, and metabolism Rule: K.S.A. 65-2871 A program claiming to manage blood sugar, digestion, and metabolism in diabetes patients constitutes treatment of systemic disease, which is not affirmatively authorized for chiropractors. | Outside scope |
| DNA and oxidative stress testing can guide personalized diabetes management Rule: K.S.A. 65-2871 DNA and oxidative stress testing for systemic disease management is not affirmatively authorized; the statute limits diagnosis to physical, thermal, manual, and X-ray methods taught in accredited chiropractic schools. | Outside scope |
| Genetic testing can predict diabetes Rule: K.S.A. 65-2871 Genetic testing to predict systemic disease is not within the chiropractic diagnostic scope, which is limited to physical, thermal, manual, and X-ray methods. | Outside scope |
| The program helps prevent kidney issues, nerve damage, and vision loss in diabetes Rule: K.S.A. 65-2871 Preventing complications of systemic disease (diabetes-related kidney, nerve, and vision damage) constitutes treatment of disease and is not affirmatively authorized for chiropractors. | Outside scope |
| Listed service Winners in Diabetes Program Rule: K.S.A. 65-2871 A named program for diabetes management is not affirmatively authorized within the chiropractic scope of practice. | Outside scope |
| Listed service The WINNERS in Diabetes Full Program Rule: K.S.A. 65-2871 A named program for diabetes management is not affirmatively authorized within the chiropractic scope of practice. | Outside scope |
| Listed service to struggle alone with diabetes Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Why the WINNERS in Diabetes Program Changes Everything Rule: K.S.A. 65-2871 Marketing language for a diabetes program is not affirmatively authorized within the chiropractic scope of practice. | Outside scope |
| Listed service Q: Can genetic testing predict diabetes? Rule: K.S.A. 65-2871 Genetic testing to predict systemic disease is not within the chiropractic diagnostic scope, which is limited to physical, thermal, manual, and X-ray methods. | Outside scope |
| Listed service Do you have genetic tendencies toward insulin resistance? Rule: K.S.A. 65-2871 Assessing genetic predisposition to metabolic disease is not affirmatively authorized; chiropractic diagnosis is limited to physical, thermal, manual, and X-ray methods. | Outside scope |
| Listed service Put Diabetes In Remission Forever! Rule: K.S.A. 65-2871 Claiming to put systemic disease into remission is treatment of disease and is not affirmatively authorized for chiropractors. | Outside scope |
| DNA and oxidative stress testing for diabetes management Rule: K.S.A. 65-2871 DNA and oxidative stress testing for systemic disease management is not affirmatively authorized; chiropractic diagnosis is limited to physical, thermal, manual, and X-ray methods. | Outside scope |
| Detox programs can reset the body and restore natural balance for metabolic problems Rule: K.S.A. 65-2871 Detox programs for metabolic disease are not affirmatively authorized; while chiropractors may use foods and food extracts, treating systemic metabolic disease is outside scope. | Outside scope |
| Metabolic weight loss can target stubborn weight linked to blood sugar imbalances Rule: K.S.A. 65-2871 Treating metabolic disease and blood sugar imbalances is not affirmatively authorized for chiropractors; this constitutes management of systemic endocrine/metabolic disease. | Outside scope |
| Fullscript supplements support healthy glucose regulation Rule: K.S.A. 65-2871 Recommending supplements to regulate glucose in diabetic patients constitutes treatment of systemic disease, which is not affirmatively authorized for chiropractors. | Outside scope |
| Continuous glucose monitoring is being added as a service Rule: K.S.A. 65-2871 Continuous glucose monitoring is a medical diagnostic device for managing systemic disease and is not affirmatively authorized within the chiropractic scope. | Outside scope |
| DNA testing plus lifestyle and supplement recommendations will work for you Rule: K.S.A. 65-2871 DNA testing combined with recommendations for systemic disease management is not affirmatively authorized; chiropractic diagnosis is limited to physical, thermal, manual, and X-ray methods. | Outside scope |
| Custom plans combine detox support, targeted nutrition, and clean supplements Rule: K.S.A. 65-2871 Custom plans for detox and targeted nutrition to treat systemic disease are not affirmatively authorized for chiropractors. | Outside scope |
| Free consultation used to identify metabolic blockers and determine whether DNA testing is the next step Rule: K.S.A. 65-2871 Identifying metabolic blockers and recommending DNA testing for systemic disease is not affirmatively authorized; chiropractic diagnosis is limited to physical, thermal, manual, and X-ray methods. | Outside scope |
| Detox programs for metabolic reset Rule: K.S.A. 65-2871 Detox programs for metabolic disease are not affirmatively authorized; while chiropractors may use foods and food extracts, treating systemic metabolic disease is outside scope. | Outside scope |
| Supplement-based glucose regulation through Fullscript Rule: K.S.A. 65-2871 Recommending supplements to regulate glucose in diabetic patients constitutes treatment of systemic disease, which is not affirmatively authorized for chiropractors. | Outside scope |
| Continuous glucose monitoring sold as part of the funnel Rule: K.S.A. 65-2871 Continuous glucose monitoring is a medical diagnostic device for managing systemic disease and is not affirmatively authorized within the chiropractic scope. | Outside scope |
Sources: K.S.A. 65-2871 - Persons deemed engaged in practice of chiropractic (official), K.S.A. 65-2802 - Definitions (official), Kansas State Board of Healing Arts - Doctor of Chiropractic (official), 2026 Kansas Statutes (official)
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Overland Park, KS. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-10-21 12:01 UTC. The archive pane loads styles and images from the intake snapshot.
1 licensed-care path linked for out-of-scope claims.
Disclaimer hypocrisy
Teresa Volner hides behind the polite little shield that the test itself does not diagnose diabetes, then immediately turns around and hands out diabetes-management advice, supplement recommendations, and a personalized treatment pathway. That’s disclaimer cosplay: the liability language stays on, but the medical advice keeps flowing.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedTess Volner clinic / principal site (totalcarehealthsolutions.com)
- OwnedOfficial site (totalcarechiro.com)
- Linked entityLinked commerce or practice (pages.talktodrtess.com)
Funnel routes (third-party)
- Hosted routeFunnel route on fullscript.com
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission 6fIm_gjeu3fQmzeCiGWbl
Fight disinformation
Log a public thread where Teresa Marie Volner is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Teresa Marie Volner's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/6fIm_gjeu3fQmzeCiGWbl. White-coat charisma isn't evidence.
Full DTMB scan on Teresa Marie Volner: https://drtrustmebro.com/analyze/6fIm_gjeu3fQmzeCiGWbl
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We could not find a public contact email for Teresa Marie Volner. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Teresa Marie Volner, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Teresa Marie Volner. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: GGcM2EgKu6U2U77APV8Us
- Wall entry: /influencer/GGcM2EgKu6U2U77APV8Us
- Analysis ID: 6fIm_gjeu3fQmzeCiGWbl
- Source: https://totalcarehealthsolutions.com/home
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [2] ASPEN-FELANPE Clinical Guidelines.
- [3] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
- [4] When Is Parenteral Nutrition Appropriate?
- [5] EFNS guideline on the treatment of tension-type headache - report of an EFNS task force.
- [6] GRADE guidelines 6. Rating the quality of evidence--imprecision.
- [7] Blood Transfusion Therapy.
- [8] Colchicine in Pericarditis.
- [9] [Network meta-analyses: Interest and limits in oncology].
- [10] Pharmacogenomics-Guided therapeutics in type 2 diabetes: Mechanisms, drug Targets, and precision medicine perspectives - PubMed
- [11] Pharmacogenetics of Type 2 Diabetes—Progress and Prospects
- [12] Oxidative stress biomarkers in type 2 diabetes - PubMed
- [13] Pharmacogenomics and Personalized Medicine in Type 2 Diabetes ...
- [14] Systematic Review of Polygenic Risk Scores for Type 1 and ... - PMC
- [15] Polygenic risk score for type 2 diabetes shows context-dependent ...
- [16] Clinical use of polygenic scores in type 2 diabetes - Springer Nature
- [17] Polygenic risk score for type 2 diabetes shows context ... - PMC
- [18] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
- [19] Decreased insulin requirements with spinal cord stimulation in a patient with diabetes - PubMed
- [20] Effect of Manual Medicine or Cognitive Behavioral Therapy With ...
- [21] The effects of 12 weeks of chiropractic spinal adjustments on ...
- [22] Cerebral metabolic changes in men after chiropractic spinal manipulation for neck pain - PubMed
- [23] Detox diets for toxin elimination and weight management - PubMed
- [24] Guided Metabolic Detoxification Program Supports Phase II ...
- [25] A Randomized Controlled Trial of Fasting and Lifestyle Modification ...
- [26] A Plant-Based Dietary Supplement Improves Measures ... - PMC
- [27] Weight loss, glycemic control, and cardiovascular disease risk ...
- [28] Effect of loss of regional fat assessed by DXA on insulin resistance and dyslipidaemia in obese men - PubMed
- [29] Glycemic Control and Weight Reduction Without Causing ... - PMC
- [30] Table 4
- [31] Safety and Efficacy of Dietary Supplements for Diabetes - PMC
- [32] Could nutrient supplements provide additional glycemic ...
- [33] Comparison of nutritional supplements for glycemic control in type 2 ...
- [34] Comparison of nutritional supplements for glycemic control in type 2 diabetes: A systematic review and network meta-analysis of randomized trials
- [35] Enhanced long-term dietary change and adherence in a nutrigenomics-guided lifestyle intervention compared to a population-based (GLB/DPP) lifestyle intervention for weight management: results from the NOW randomised controlled trial
- [36] Nutrigenomics, Overweight/Obesity and Weight Management Trial (NOW Trial) (NOW)
- [37] Nutrigenomics-guided lifestyle intervention programmes: A critical ...
- [38] Nutrigenetics—personalized nutrition in obesity and cardiovascular ...
- [39] Effect of toxic trace element detoxification, body fat reduction ...
- [40] A Plant-Based Dietary Supplement Improves Measures of ...
- [41] Executive Summary of the 2020 Academy of Nutrition and Dietetics ...